|
Match
|
Document |
Document Title |
|
|
US20090317442 |
Super Elastic Epoxy Hydrogel
Described is a super elastic epoxy hydrogel that is easy to manufacture and can be engineered for various performance enhancements of the polymer. Also described are methods of enhancing the...
|
|
|
US20090317869 |
METHODS AND COMPOSITIONS FOR MAKING ANTIBODIES AND ANTIBODY DERIVATIVES WITH REDUCED CORE FUCOSYLATION
The invention provides methods and compositions for preparing antibodies and antibody derivatives with reduced core fucosylation.
|
|
|
US20090305954 |
HISTIDINE-CONTAINING DIASTEREOMERIC PEPTIDES AND USES THEREOF
Diastereomeric peptides with a net positive charge greater than +1, and cyclic derivatives thereof, are provided, having at least 13 amino acid residues, comprising histidine and one or more...
|
|
|
US20090305401 |
PLASMA-FREE PLATELET LYSATE FOR USE AS A SUPPLEMENT IN CELL CULTURES AND FOR THE PREPARATION OF CELL THERAPEUTICS
The present invention provides a cell culture medium supplement comprising plasma-free platelet lysate and medium supplemented with this supplement. The present invention further provides a method...
|
|
|
US20090305414 |
Methods Of Tissue Engineering
An improved substrate for growing mono-layers of adherent-type cells and methods of growing tissue structures, ex vivo. The improved substrate, which comprises a silicon substrate coated with a...
|
|
|
US20090291501 |
Rapid Dissolve Media
A method for producing a palletized material includes mixing a media powder with a treated water ( 100 ), the treated water comprising an additive for substantially preventing bacterial...
|
|
|
US20090280095 |
CELL CULTURE OF KERATINOCYTES UNDER NON-DIFFERENTIATING CONDITIONS
The present invention relates to a cell culture medium comprising (a) an inhibitor of bone morphogenetic protein-4 (BMP-4) and (b) an inhibitor of pigment epithelium-derived factor (PEDF, also...
|
|
|
US20090280097 |
PLURIPOTENT CELLS
Pluripotent cells that are immunopositive for both the neural progenitor marker nestin and a pluripotent cell marker are provided. The cells exhibit rapid doubling times and can be maintained in...
|
|
|
US20090269848 |
TECHNIQUE FOR CULTURE OF MESENCHYMAL STEM CELL UTILIZING LAMININ-5
Disclosed is an agent for improving at least one activity selected from the group consisting of the growth activity, adhesion activity and extension activity of mesenchymal stem cells, which...
|
|
|
US20090263429 |
Method of Preparing a Hydrogel
A method of preparing a hydrogel comprises: (i) reacting a first molecule comprising a carboxylic acid group and second molecule comprising an amine group or an alcohol group with a hydrolase...
|
|
|
US20090250609 |
Inspection Method and Reagent Solution
An electron microscope method for inspecting a liquid specimen and a reagent solution therefor. A culture medium and biological cells are put in the sample holder. A plugging agent is mixed into...
|
|
|
US20090253134 |
Cellular Pyrogen Test
The invention concerns methods, agents and kits for qualitative and quantitative detection and identification of pathogens and pathogen spectra based on endotoxins and other pyrogens.
|
|
|
US20090246868 |
Serum-free vero cell banking process
A serum-free Vero cell banking process provides a standardized and consistent way to generate reliable and stable cell banks for viral vaccine production. The substitution of animal-derived...
|
|
|
US20090238799 |
Conditionally-Immortalised Pancreatic Cells
Conditionally immortalized pancreatic cells are produced which remain immortal in the presence of 4-hydroxytamoxifen (4-OHT) but express normal pancreatic cell markers when 4-OHT is not present....
|
|
|
US20090238853 |
Hybrid Biomedical Device Fabricated From Biomaterials and Coated With a Natural Extra Cellular Matrix (ECM) Coating
The present invention relates to a hybrid biomedical device formed from a prefabricated biomedical device and coated with an extracellular matrix coating which is produced by directly culturing...
|
|
|
US20090233363 |
Dedifferentiated, Programmable Stem Cells of Monocytic Origin, and Their Production and Use
The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The...
|
|
|
US20090227027 |
COATED CELL CULTURE SURFACES AND METHODS THEREOF
A composition for use, for example, in cell culture surface modification and in cell culture articles, as defined herein. Also disclosed are methods of making the compositions and articles, and...
|
|
|
US20090226879 |
Protein-Free Gamete and Embryo Handling and Culture Media Products
This invention discloses a substantially protein-free cell culture solution for assisted reproductive technologies and methods of use thereof.
|
|
|
US20090221077 |
Process for producing cytotoxic lymphocytes
The present invention provides a method for preparing a cytotoxic lymphocyte characterized in that the method comprises the step of carrying out at least one step selected from induction,...
|
|
|
US20090202498 |
DIRECT DIFFERENTIATION OF CARDIOMYOCYTES FROM HUMAN EMBRYONIC STEM CELLS
The present invention relates to the induction of differentiation in stem cells to cardiomyocytes and factors such as prostaglandin alone or in combination with other factors including essential...
|
|
|
US20090203076 |
COMPOSITIONS AND METHODS FOR INCREASING PROTEIN PRODUCTION
Compositions and methods for increasing protein production are provided.
|
|
|
US20090202653 |
Compositions and method for enhancing proteoglycan production
The present invention provides compositions comprising notochord enriched media and/or one or more factors derived therefrom. Such compositions are useful for enhancing the production of...
|
|
|
US20090191161 |
TENOCYTE CELL CULTURING METHOD
The present invention relates to a method for culturing tenocytes. In particular the present invention relates to a method for culturing tenocytes comprising the step of incubating tenocytes in a...
|
|
|
US20090186408 |
Biocompatible bilayer porous matrix and preparation thereof
The present invention provides a biocompatible bilayer porous matrix and preparation thereof. The bilayer porous matrix is composed of gelatin, chondroitin 6 sulfate, and hyaluronic acid, also,...
|
|
|
US20090156890 |
PEROXISOME PROLIFERATOR-ACTIVATOR RECEPTOR DELTA (PPARDELTA) AND THE DEVELOPMENT OF PREIMPLANTATION EMBRYOS
Methods and compositions for enhancing development of a preimplantation mammalian embryo and for increasing the live birth potential of an in vitro fertilized mammalian embryo are disclosed. An in...
|
|
|
US20090155906 |
CELL DIFFERENTIATION SUPPRESSING AGENT, METHOD OF CULTURING CELLS USING THE SAME, CULTURE SOLUTION, AND CULTURED CELL LINE
The object of the present invention is to provide a differentiation inhibiting agent which allows culture of a stem cell or an embryonic stem cell in an undifferentiated state without use of any...
|
|
|
US20090148425 |
THERAPEUTIC METHOD FOR BLOOD COAGULATION DISORDER
The present invention provides agents for treating blood coagulation abnormalities, which contain as an active ingredient a lentiviral vector carrying a blood coagulation factor gene operably...
|
|
|
US20090148945 |
Novel Biodegradable Elastomeric Scaffold for Tissue Engineering and Light Scattering Fingerprinting Methods for Testing the Same
The present invention is directed to a novel biocompatible polymer that may be used in tissue engineering. More specifically, the specification describes methods and compositions for making and...
|
|
|
US20090142839 |
Inducing Premature Senescence to Stabilize Stem Cell Feeder Layer Cells
The present invention provides stem cell feeder layer cell lines that contain are readily triggered to differentiation. The expression vector encodes the senescence-triggering factors (STFs)...
|
|
|
US20090143248 |
Biologically active C-terminal arginine-containing peptides
The present invention concerns the separation, identification and characterization of active peptide fragments from peptones.
|
|
|
US20090130759 |
Culture Medium Containing Kinase Inhibitor, and Use Thereof
Pluripotent cells are maintained in a self-renewing state in serum-free culture medium comprising a gp130 agonist (LIF) and a GSK3 inhibitor.
|
|
|
US20090123975 |
FEED MEDIA
The invention provides stable feed media containing pyruvate and methods for stabilizing feed media by adding pyruvate. The invention further provides methods for producing proteins using such...
|
|
|
US20090124006 |
Serum-Free Culture Medium for the Production of Recombinant Gonadotropins
The present invention is in the field of the manufacture of recombinant proteins. More specifically, it relates to the use of a serum-free culture medium comprising an antioxidant for the...
|
|
|
US20090117654 |
MEDIUM FOR CULTURING HEMATOPOIETIC CELLS AND A METHOD OF CULTURING HEMATOPOIETIC CELLS
Provided are a medium for culturing hematopoietic cells including lysyl oxidase inhibitor and a method of culturing hematopoietic cells using the medium.
|
|
|
US20090104695 |
Stem Cells Culture Systems
The present invention concerns systems and methods for providing human cell cultures. Specific embodiments of the invention relate to cultures of feeder cells for use in stem cell technology, as...
|
|
|
US20090098159 |
Feline Cell Capable of Being Cultured Without Animal-Derived Protein, and Method for producing virus and method for producing vaccine using thereof
The present invention provides a cell strain which is derived from an fcwf-4 cell that is a cell derived from a feline whole fetus and which is capable of being cultured without animal-derived...
|
|
|
US20090075380 |
Methods and Compositions To Enhance Efficiency Of Nuclear Transfer/Cloning
The present invention provides compositions and methods for increasing the success of assisted reproductive technology (ART). Specifically, the inventions described herein increase the survival...
|
|
|
US20090074832 |
Medical Scaffold, Methods of Fabrication and Using Thereof
Articles of manufacturing comprising electrospun elements having continuous or stepwise gradients of porosity, average pore size, weight per volume and/or of agents for promoting cell colonization,...
|
|
|
US20090068705 |
Use of Copper Glutamate in Cell Culture for Production of Polypeptides
An improved system for large scale production of polypeptides in cell culture is provided. In accordance with the present invention, cells expressing a polypeptide of interest are grown in media...
|
|
|
US20090053806 |
COATING SOLUTION AND METHOD FOR CAPTURING AND PRESERVING BIOLOGICAL MATERIALS
The present invention is directed to a coating solution for capturing and preserving biological materials. The coating solution includes at least one saccharide. The coating solution may also...
|
|
|
US20090042804 |
NOVEL PEPTIDE AMPHIPHILES HAVING IMPROVED SOLUBILITY AND METHODS OF USING SAME
Disclosed herein are novel peptide amphiphile molecules and compositions discovered to possess improved solubility in aqueous buffers which, in turn, facilitates purification required for...
|
|
|
US20090035346 |
Methods and Compositions for Enhancing Vascular Access
Disclosed is an implantable material comprising a biocompatible matrix and cells which, when provided to a vascular access structure, can promote functionality generally. For example, implantable...
|
|
|
US20090028831 |
STEM CELL REGULATOR, COMPOSITIONS AND METHODS OF USE
The disclosure provides methods and compositions comprising Slit2 agonists and antagonists useful for modulating hematopoietic stem cell (HSC) proliferation and growth. In some aspects, the...
|
|
|
US20090011453 |
Methods for Producing Proteins Using Hamster Igf-1
A polypeptide selected from the group consisting of: (1) a polypeptide having the amino acid sequence of SEQ ID NO: 1, and (2) a polypeptide having an amino acid sequence in which the third amino...
|
|
|
US20090004150 |
Method for Expanding Postembryonic Stem and Progenitor Cells from Umbilical Cord Blood and Immunotherapeutic Agent
Method for obtaining and expanding postembryonic hematopoietic stem cells from umbilical cord blood while avoiding unwanted differentiation. Initial cells from umbilical cord blood are proliferated...
|
|
|
US20080311660 |
Dry powder cell culture products and methods of production thereof
The present invention relates to nutritive medium, medium supplement, media subgroup and buffer formulations. The present invention provides powder nutritive medium, medium supplement and medium...
|
|
|
US20080299167 |
Vascular Endothelial Growth Factors And Methods Of Their Use
Vascular endothelial growth factor alternative splice variants and methods of their use are provided.
|
|
|
US20080299540 |
Hormone responsive tissue culture system and uses thereof
The invention provides tissue culture system for primary cells (e.g. normal mammalian primary epithelial progenitors). This system includes: a) a serum-free, chemically defined cell culture media;...
|
|
|
US20080299535 |
Preservative Solution for Cells, Tissues and Organs Comprising Rare Sugar and Preservation Method with the Use of the Same
[Problem] To provide a preservative solution for cells, tissues and organs using a rare sugar and a preservation method using the solution. [Means for Resolution] A preservative solution for...
|
|
|
US20080286862 |
Physiochemical Culture Conditions for Embryonic Stem Cells
Physiochemical parameters to improve the culturing and sub-culturing (here called cloning) of human embryonic stem cells have been investigated. Low levels of oxygen and higher than expected levels...
|